Raloxifene Tablet: Uses, Side Effects and Dosage
Written by Medicover Team and Medically Reviewed by Dr Afshaan Shaik, Gynecology
Raloxifene is a medication commonly used to treat and prevent osteoporosis in postmenopausal women. It helps strengthen bones and reduces the risk of fractures by acting like estrogen on bone tissue. Raloxifene is also sometimes used to lower the risk of invasive breast cancer in certain women.
The usual dose of Raloxifene is 60 mg once daily, taken with or without food. While generally well-tolerated, it may cause side effects such as hot flashes, leg cramps, or a risk of blood clots in rare cases.
Raloxifene is a prescription medication used primarily by postmenopausal women to prevent and treat osteoporosis (bone loss). It helps maintain bone density and reduces the likelihood of fractures. Additionally, Raloxifene can decrease the risk of invasive breast cancer in postmenopausal women.
It is a selective estrogen receptor modulator (SERM) that mimics the effects of estrogen on bones while blocking estrogen's effects on other tissues, such as the breast and uterus. However, it does not alleviate menopausal symptoms like hot flashes.
Raloxifene is used for:
Get a second opinion from trusted experts and makeconfident, informed decisions.
Get Second OpinionRaloxifene side effects may include swelling, and increased risk of blood clots. These occur because raloxifene acts like estrogen in some tissues (bones) and blocks it in others (breast, uterus), affecting hormone balance, blood flow, and clotting mechanisms, especially in postmenopausal women.
If you experience serious side effects, contact your doctor immediately.
Before taking Raloxifene, inform your doctor if you:
| Raloxifene | Femara |
|---|---|
|
|

Still have questions? Speak with our experts now!
040-68334455Raloxifene is used to prevent and treat osteoporosis in postmenopausal women. It also reduces the risk of invasive breast cancer in postmenopausal women with osteoporosis or at high risk of developing breast cancer.
Raloxifene works by binding to estrogen receptors in various tissues. Depending on the tissue, it can have estrogenic effects (activating estrogen pathways) or anti-estrogenic effects (blocking estrogen pathways).
No, raloxifene is not a hormone. It is classified as a selective estrogen receptor modulator (SERM), which interacts with estrogen receptors in a selective manner.
Weight gain of more than 10 pounds is less common with raloxifene compared to some other medications. However, individual responses may vary, and factors like duration of therapy can influence weight changes.
Disclaimer: The information provided is accurate and up-to-date to the best of our knowledge. However, it should not be considered a substitute for medical advice or consultation. We do not guarantee its completeness or accuracy. The absence of specific warnings does not mean a medicine is safe for all users. We are not responsible for any outcomes based on this information and strongly recommend consulting a doctor for any medical concerns or questions.